Three Decades at the Intersection of Ophthalmology, Epidemiology and Health Economics.
MedMetrics brings unusually deep experience in the
economics, epidemiology and outcomes of eye disease.
Our work has addressed questions ranging from the economic
burden of visual impairment and cost-effectiveness of screening to the value of
pharmaceuticals, medical devices and alternative models of eye-care delivery.
Clinical efficacy alone does not determine whether an intervention will improve population eye health.
MedMetrics' examines the broader pathway:
Detection → Diagnosis → Referral → Treatment → Outcomes →
Costs → Health Value → Implementation
This enables research to address not only whether an
intervention works, but whether it represents good value, how it should be
delivered, and whether it can be implemented sustainably at scale.